Match!
Michael Goldstein
Beth Israel Deaconess Medical Center
38Publications
18H-index
1,774Citations
Publications 38
Newest
Background: There are limited treatment options available for patients with advanced pancreatic ductal adenocarcinoma (PDAC). We conducted a phase II study evaluating the efficacy and safety of capecitabine/oxaliplatin (CAPOX) in patients with locally advanced and metastatic PDAC treated in the first and second lines. Methods: Forty subjects with advanced PDAC and ECOG performance status ≥2 were enrolled. Treatment consisted of capecitabine 2,000 mg/m 2 orally in two divided doses daily for 14 d...
3 CitationsSource
8050 Background: Identification of somatic molecular alterrations in NSCLC has become evidence-based practice. The success and failure rate of using commercially-available tumor genotyping techniques in routine day-to-day NSCLC pathology samples is not well described. We sought to evaluate the success and failure rate of EGFR mutation, KRAS mutation and ALK FISH. Methods: Clinicopathologic data, tumor genotype success and failure rates were retrospectively compiled and analyzed from 381 patient-...
1 Citations
#1Chun Chieh Lin (ACS: American Cancer Society)H-Index: 17
#2Suanna S. Bruinooge (American Society of Clinical Oncology)H-Index: 15
Last.Christine Olsen (Harvard University)H-Index: 5
view all 16 authors...
Purpose Trimodality therapy (chemoradiation and surgery) is the standard of care for stage II/III rectal cancer but nearly one third of patients do not receive radiation therapy (RT). We examined the relationship between the density of radiation oncologists and the travel distance to receipt of RT. Methods and Materials A retrospective study based on the National Cancer Data Base identified 26,845 patients aged 18 to 80 years with stage II/III rectal cancer diagnosed from 2007 to 2010. Radiation...
17 CitationsSource
#1Chun Chieh Lin (ACS: American Cancer Society)H-Index: 17
#2Suanna S. Bruinooge (American Society of Clinical Oncology)H-Index: 15
Last.Christine Olsen (Harvard University)H-Index: 5
view all 16 authors...
Source
#1Chun Chieh Lin (ACS: American Cancer Society)H-Index: 17
#2Suanna S. Bruinooge (American Society of Clinical Oncology)H-Index: 15
Last.Dawn L. Hershman (Columbia University)H-Index: 58
view all 16 authors...
Purpose Geographic access to care may be associated with receipt of chemotherapy but has not been fully examined. This study sought to evaluate the association between density of oncologists and travel distance and receipt of adjuvant chemotherapy for colon cancer within 90 days of colectomy. Patients and Methods Patients in the National Cancer Data Base with stage III colon cancer, diagnosed between 2007 and 2010, and age 18 to 80 years were selected. Generalized estimating equation clustering ...
51 CitationsSource
#1Erik Folch (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 17
#2Adnan MajidH-Index: 22
Last.Daniel B. CostaH-Index: 39
view all 12 authors...
Source
#1Paul A. VanderLaan (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 22
#2Norihiro Yamaguchi (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 9
Last.Daniel B. Costa (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 39
view all 11 authors...
Abstract Introduction Identification of some somatic molecular alterations in non-small-cell lung cancer (NSCLC) has become evidence-based practice. The success and failure rate of using commercially available tumor genotyping techniques in routine day-to-day NSCLC pathology samples is not well described. We sought to evaluate the success and failure rate of EGFR mutation, KRAS mutation, and ALK FISH in a cohort of lung cancers subjected to routine clinical tumor genotype. Methods Clinicopatholo...
55 CitationsSource
Efforts to survey oncologists about practice patterns will help determine whether productivity and service delivery will change significantly. ASCO is committed to tracking oncologist supply and demand and providing analysis of strategies to address shortages.
21 CitationsSource
#1Marcia M. WardH-Index: 33
#2Fred UllrichH-Index: 9
Last.Charles F. LynchH-Index: 82
view all 12 authors...
The authors examine access issues in Iowa and determine a methodology for conducting a national analysis.
10 CitationsSource
#1Wenya YangH-Index: 6
#2James H. WilliamsH-Index: 2
Last.Michael GoldsteinH-Index: 18
view all 11 authors...
Anticipated oncologist shortages are largely consistent with the ASCO 2007 workforce study but somewhat more delayed. The ACA may exacerbate the shortage.
74 CitationsSource
1234